Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1138245-21-2
2. Mirogabalin Besilate
3. Mirogabalin Besylate [usan]
4. 01f4frp8yl
5. 2-[(1r,5s,6s)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic Acid;benzenesulfonic Acid
6. Mirogabalin Besilate (jan)
7. Mirogabalin Besylate (usan)
8. 2-((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic Acid Compound With Benzenesulfonic Acid (1:1)
9. Bicyclo(3.2.0)hept-3-ene-6-acetic Acid, 6-(aminomethyl)-3-ethyl-, (1r,5s,6s)-, Benzenesulfonate (1:1)
10. Mirogabalin Besilate [jan]
11. Unii-01f4frp8yl
12. Mirogabalin Besilate [who-dd]
13. Schembl1883872
14. Chembl3545257
15. Amy16760
16. Ex-a2817
17. Mfcd31631215
18. Ac-30336
19. Hy-108006
20. Cs-0027136
21. D10790
22. A901402
23. 2-((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic Acid Besylate
24. 2-((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)aceticacidbesylate
25. ((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo(3.2.0)hept-3-en-6-yl)acetic Acid Monobenzenesulfonate
26. [(1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic Acid Benzenesulfonate;
Molecular Weight | 367.5 g/mol |
---|---|
Molecular Formula | C18H25NO5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 367.14534407 g/mol |
Monoisotopic Mass | 367.14534407 g/mol |
Topological Polar Surface Area | 126 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 494 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41196
Submission : 2025-02-12
Status : Active
Type : II
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2024-06-14
Registration Number : Thu21-27-ND
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No.10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana State, 502319, India
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39342
Submission : 2023-12-29
Status : Active
Type : II
Registrant Name : Iksoo Pharmaceutical Co., Ltd.
Registration Date : 2025-03-11
Registration Number : Su69-20-ND
Manufacturer Name : Ami Lifesciences Pvt. Ltd.
Manufacturer Address : Block No. 82/B, ECP Road, At & Post: Karakhadi-391450, Taluka: Padra, District : Vadodara, Gujarat, India
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Sungwoo Chemical Co., Ltd.
Registration Date : 2025-02-28
Registration Number : Thu21-27-ND(2)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No. 10/G-1, Gaddapotharam Village Jinnaram Mandal, Sangareddy District Telangana State, 502319, India
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Grace Farm
Registration Date : 2024-07-17
Registration Number : 21-27-ND(A)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Sy. No. 10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana State, 502319 India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41196
Submission : 2025-02-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39342
Submission : 2023-12-29
Status : Active
Type : II
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38908
Submission : 2023-09-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40892
Submission : 2024-12-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41755
Submission : 2025-06-27
Status : Active
Type : II
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Date of Issue : 2022-06-15
Valid Till : 2025-07-28
Written Confirmation Number : WC-0186
Address of the Firm : Sy. No. 10/G-1, Gaddapotharam (V), Jinnaram (M), Sangareddy District, Pincode 50...
Registrant Name : Iksoo Pharmaceutical Co., Ltd.
Registration Date : 2025-03-11
Registration Number : Su69-20-ND
Manufacturer Name : Ami Lifesciences Pvt. Ltd.
Manufacturer Address : Block No. 82/B, ECP Road, At & Post: Karakhadi-391450, Taluka: Padra, District : Vado...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2024-06-14
Registration Number : Thu21-27-ND
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No.10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telang...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2025-04-02
Registration Number : Thu21-27-ND(B)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Sy no. 10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Pharmawon Co., Ltd.
Registration Date : 2025-06-02
Registration Number : Thu21-27-ND(5)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No. 10/G-1, Gaddapotharam Village Jinnaram Mandal, Sangareddy District Telanga...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Samjin Pharmaceutical Co., Ltd.
Registration Date : 2025-03-17
Registration Number : Thu21-27-ND(4)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No. 10/G-1, Gaddapotharam Village Jinnaram Mandal, Sangareddy District Telanga...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Lihu Healthcare Co., Ltd.
Registration Date : 2025-03-14
Registration Number : Thu21-27-ND(3)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No. 10/G-1, Gaddapotharam Village Jinnaram Mandal, Sangareddy District Telanga...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2024-07-17
Registration Number : Thu21-27-ND(1)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No.10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telang...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Grace Farm
Registration Date : 2024-07-17
Registration Number : 21-27-ND(A)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Sy. No. 10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangan...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Registrant Name : Sungwoo Chemical Co., Ltd.
Registration Date : 2025-02-28
Registration Number : Thu21-27-ND(2)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No. 10/G-1, Gaddapotharam Village Jinnaram Mandal, Sangareddy District Telanga...
Registrant Name : Korea Daiichi Sankyo Co., Ltd.
Registration Date : 2020-01-23
Registration Number : Su256-4-ND
Manufacturer Name : DAIICHI SANKYO CHEMICAL PHAR...
Manufacturer Address : 477, Takada, Odawara, Kanagawa, Japan
NDC Package Code : 81999-0015
Start Marketing Date : 2025-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
About the Company : Lee Pharma Ltd, established in 1997, is a research-driven pharmaceutical company focused on developing and commercializing high-quality APIs, intermediates, and finished formulatio...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
About the Company : HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-g...
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
About the Company : Honour is a leading global CDMO and a trusted manufacturer of specialty chemicals and ingredients. With seven world-class facilities built to meet global safety and quality standar...
About the Company : Sichuan Qingmu Pharmaceutical Co., Ltd. is an innovation-driven pharmaceutical company focused on regulated markets. We specialize in the R&D and manufacturing of generic APIs and ...
About the Company : Beijing Sjar Technology Development Co., Ltd. founded in 2014, it is a high-tech enterprise which specialized in the research and development of active pharmaceutical ingredients a...
About the Company : Flax Laboratories was established by a group of young and experienced professionals with the specific objective to develop and produce complex, small volume, technology driven bulk...
About the Company : Hope Chem is dedicated to manufacturing, marketing, and CMO service of Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals since the year 2010. Current...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Undisclosed
Lead Product(s): Mirogabalin Besylate,BM2216
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 26, 2025
Lead Product(s) : Mirogabalin Besylate,BM2216
Therapeutic Area : Neurology
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 26, 2025
Details:
Tarlige® (mirogabalin besilate), is an analgesic works by inhibiting the excessive release of pain-related neurotransmitters in presynaptic nerve terminal, ® was approved for the indication of “peripheral neuropathic pain” in Japan.
Lead Product(s): Mirogabalin Besylate,Inapplicable
Therapeutic Area: Neurology Brand Name: Tarlige
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 28, 2022
Lead Product(s) : Mirogabalin Besylate,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Tarlige® Tablets Approved in Japan for Treatment of Patients with Neuropathic Pain
Details : Tarlige® (mirogabalin besilate), is an analgesic works by inhibiting the excessive release of pain-related neurotransmitters in presynaptic nerve terminal, ® was approved for the indication of “peripheral neuropathic pain” in Japan.
Product Name : Tarlige
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 28, 2022
Details:
Undisclosed
Lead Product(s): Mirogabalin Besylate,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 19, 2019
Lead Product(s) : Mirogabalin Besylate,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 19, 2019
Details:
Undisclosed
Lead Product(s): Mirogabalin Besylate,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 03, 2019
Lead Product(s) : Mirogabalin Besylate,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Mirogabalin for Central Neuropathic Pain
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 03, 2019
(1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one
CAS Number : 1235479-61-4
End Use API : Mirogabalin Besylate
About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...
(1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one
CAS Number : 1235479-61-4
End Use API : Mirogabalin Besylate
About The Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Activ...
Global Sales Information
Market Place
ABOUT THIS PAGE
98
PharmaCompass offers a list of Mirogabalin Besylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mirogabalin Besylate manufacturer or Mirogabalin Besylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mirogabalin Besylate manufacturer or Mirogabalin Besylate supplier.
PharmaCompass also assists you with knowing the Mirogabalin Besylate API Price utilized in the formulation of products. Mirogabalin Besylate API Price is not always fixed or binding as the Mirogabalin Besylate Price is obtained through a variety of data sources. The Mirogabalin Besylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mirogabalin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mirogabalin, including repackagers and relabelers. The FDA regulates Mirogabalin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mirogabalin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mirogabalin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mirogabalin supplier is an individual or a company that provides Mirogabalin active pharmaceutical ingredient (API) or Mirogabalin finished formulations upon request. The Mirogabalin suppliers may include Mirogabalin API manufacturers, exporters, distributors and traders.
click here to find a list of Mirogabalin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mirogabalin DMF (Drug Master File) is a document detailing the whole manufacturing process of Mirogabalin active pharmaceutical ingredient (API) in detail. Different forms of Mirogabalin DMFs exist exist since differing nations have different regulations, such as Mirogabalin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mirogabalin DMF submitted to regulatory agencies in the US is known as a USDMF. Mirogabalin USDMF includes data on Mirogabalin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mirogabalin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mirogabalin suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mirogabalin Drug Master File in Korea (Mirogabalin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mirogabalin. The MFDS reviews the Mirogabalin KDMF as part of the drug registration process and uses the information provided in the Mirogabalin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mirogabalin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mirogabalin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mirogabalin suppliers with KDMF on PharmaCompass.
A Mirogabalin written confirmation (Mirogabalin WC) is an official document issued by a regulatory agency to a Mirogabalin manufacturer, verifying that the manufacturing facility of a Mirogabalin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mirogabalin APIs or Mirogabalin finished pharmaceutical products to another nation, regulatory agencies frequently require a Mirogabalin WC (written confirmation) as part of the regulatory process.
click here to find a list of Mirogabalin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mirogabalin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mirogabalin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mirogabalin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mirogabalin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mirogabalin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mirogabalin suppliers with NDC on PharmaCompass.
Mirogabalin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mirogabalin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mirogabalin GMP manufacturer or Mirogabalin GMP API supplier for your needs.
A Mirogabalin CoA (Certificate of Analysis) is a formal document that attests to Mirogabalin's compliance with Mirogabalin specifications and serves as a tool for batch-level quality control.
Mirogabalin CoA mostly includes findings from lab analyses of a specific batch. For each Mirogabalin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mirogabalin may be tested according to a variety of international standards, such as European Pharmacopoeia (Mirogabalin EP), Mirogabalin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mirogabalin USP).